Robert Ho - Net Worth and Insider Trading
Robert Ho Net Worth
The estimated net worth of Robert Ho is at least $3,752 dollars as of 2024-09-21. Robert Ho is the CFO of Neoleukin Therapeutics Inc and owns about 1,075 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $3,752. Details can be seen in Robert Ho's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Ho has not made any transactions after 2021-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Ho
Robert Ho Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Ho owns 2 companies in total, including Neoleukin Therapeutics Inc (NLTX) , and Third Harmonic Bio Inc (THRD) .
Click here to see the complete history of Robert Ho’s form 4 insider trades.
Insider Ownership Summary of Robert Ho
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NLTX | Neoleukin Therapeutics Inc | 2021-03-17 | Chief Financial Officer |
THRD | Third Harmonic Bio Inc | 2022-09-14 | Chief Financial Officer |
Robert Ho Latest Holdings Summary
Robert Ho currently owns a total of 1 stock. Robert Ho owns 1,075 shares of Neoleukin Therapeutics Inc (NLTX) as of March 17, 2021, with a value of $3,752.
Latest Holdings of Robert Ho
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NLTX | Neoleukin Therapeutics Inc | 2021-03-17 | 1,075 | 3.49 | 3,752 |
Holding Weightings of Robert Ho
Robert Ho Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Ho has made a total of 1 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 325 shares on March 17, 2021, which brought Robert Ho around $71,532.
Insider Trading History of Robert Ho
- 1
Robert Ho Trading Performance
Robert Ho Ownership Network
Robert Ho Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Robert Ho is the Chief Financial Officer of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Robert Ho made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , a net sale of 3,769 shares made by Priti Patel , and a net sale of 1,323 shares made by Sean Michael Smith .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 255 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,013 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
Robert Ho Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Ho. You might contact Robert Ho via mailing address: 360-1616 Eastlake Avenue East, Seattle Wa 98102.